Sign in
4

Changes in Ownership

Sonoma Pharmaceuticals, Inc. Filed Acc 0001019687-12-003013

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Miller Robert E · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2012-08-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 852,064 D
Loading xslF345X03/miller_frm4-082412.xml…